About Index Trending news
Analyze
Top 50 Pricing
Trevena

Trevena

Work at Trevena? Add yourself to this profile

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$45,000,000
Venture capital (Series C)
$60,000,000
Employees

Team size

10+
The Motley Fool

Here's Why Trevena Stock Dropped 18% Today

The Motley Fool

Why Trevena Inc.'s Shares Broke Through Today

Health Stock markets